Accolade, Inc. - stock earnings
ACCD Upcoming estimated earnings
| Date | Actual / Estimated EPS | Low Revenue | Actual / Estimated Revenue | High Revenue |
|---|---|---|---|---|
| Aug. 7, 2024 BeforeMarket | - / - | 104.3 million | - / 106.4 million | 112.8 million |
ACCD Quarterly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023Q1 | ? USD | 99.0 million USD |
| 2022Q4 | -39.9 million USD | 90.9 million USD |
| 2022Q3 | -46.5 million USD | 87.6 million USD |
| 2022Q2 | -342.8 million USD | 85.5 million USD |
| 2022Q1 | -34.6 million USD | 93.8 million USD |
| 2021Q4 | 22.5 million USD | 83.5 million USD |
| 2021Q3 | -62.4 million USD | 73.3 million USD |
| 2021Q2 | -48.7 million USD | 59.5 million USD |
| 2021Q1 | -4.7 million USD | 59.2 million USD |
| 2020Q4 | -16.6 million USD | 38.4 million USD |
| 2020Q3 | -15.4 million USD | 36.8 million USD |
ACCD Yearly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2024 | -99.8 million USD | 414.3 million USD |
| 2023 | -459.7 million USD | 363.1 million USD |
| 2022 | -123.1 million USD | 310.0 million USD |
| 2021 | -50.7 million USD | 170.4 million USD |
| 2020 | -51.4 million USD | 132.5 million USD |
| 2019 | -56.5 million USD | 94.8 million USD |
| 2018 | -61.3 million USD | 76.8 million USD |
ACCD
Price: $7.40
52 week price:
Earnings Per Share: -1.62 USD
P/E Ratio: -8.02
Exchange: NMS
Sector: Healthcare
Industry: Health Information Services
Volume: 1.5 million
Market Capitalization: 597.9 million